113 related articles for article (PubMed ID: 36756748)
21. Knockdown of mediator complex subunit 19 inhibits the growth of ovarian cancer.
Liu Y; Tao X; Fan L; Jia L; Gu C; Feng Y
Mol Med Rep; 2012 Nov; 6(5):1050-6. PubMed ID: 22961438
[TBL] [Abstract][Full Text] [Related]
22. Osteopontin is involved in TLR4 pathway contributing to ovarian cancer cell proliferation and metastasis.
Xu C; Li H; Yin M; Yang T; An L; Yang G
Oncotarget; 2017 Nov; 8(58):98394-98404. PubMed ID: 29228698
[TBL] [Abstract][Full Text] [Related]
23. Knockdown of JARID2 inhibits the proliferation and invasion of ovarian cancer through the PI3K/Akt signaling pathway.
Cao J; Li H; Liu G; Han S; Xu P
Mol Med Rep; 2017 Sep; 16(3):3600-3605. PubMed ID: 28765957
[TBL] [Abstract][Full Text] [Related]
24. SPARC is a key regulator of proliferation, apoptosis and invasion in human ovarian cancer.
Chen J; Wang M; Xi B; Xue J; He D; Zhang J; Zhao Y
PLoS One; 2012; 7(8):e42413. PubMed ID: 22879971
[TBL] [Abstract][Full Text] [Related]
25. Expression Of BMP7 In Ovarian Cancer And Biological Effect Of BMP7 Knockdown On Ovarian Cancer Cells.
Guan H; Li J; Sun R; Liu W; Feng M; Ma H; Li C
Onco Targets Ther; 2019; 12():7897-7909. PubMed ID: 31576147
[TBL] [Abstract][Full Text] [Related]
26. Iloprost, a prostacyclin analog, inhibits the invasion of ovarian cancer cells by downregulating matrix metallopeptidase-2 (MMP-2) through the IP-dependent pathway.
Ahn JH; Lee KT; Choi YS; Choi JH
Prostaglandins Other Lipid Mediat; 2018 Jan; 134():47-56. PubMed ID: 29292033
[TBL] [Abstract][Full Text] [Related]
27. FAM83D inhibits autophagy and promotes proliferation and invasion of ovarian cancer cells via PI3K/AKT/mTOR pathway.
Zhu H; Diao S; Lim V; Hu L; Hu J
Acta Biochim Biophys Sin (Shanghai); 2019 May; 51(5):509-516. PubMed ID: 30939187
[TBL] [Abstract][Full Text] [Related]
28. Effects of metastasis-associated in colon cancer 1 inhibition by small hairpin RNA on ovarian carcinoma OVCAR-3 cells.
Zhang R; Shi H; Chen Z; Wu Q; Ren F; Huang H
J Exp Clin Cancer Res; 2011 Sep; 30(1):83. PubMed ID: 21923915
[TBL] [Abstract][Full Text] [Related]
29. SIRT1 RNAi knockdown induces apoptosis and senescence, inhibits invasion and enhances chemosensitivity in pancreatic cancer cells.
Zhao G; Cui J; Zhang JG; Qin Q; Chen Q; Yin T; Deng SC; Liu Y; Liu L; Wang B; Tian K; Wang GB; Wang CY
Gene Ther; 2011 Sep; 18(9):920-8. PubMed ID: 21677689
[TBL] [Abstract][Full Text] [Related]
30. Decreased expression of peroxiredoxin1 inhibits proliferation, invasion, and metastasis of ovarian cancer cell.
Zheng MJ; Wang J; Wang HM; Gao LL; Li X; Zhang WC; Gou R; Guo Q; Nie X; Liu JJ; Lin B
Onco Targets Ther; 2018; 11():7745-7761. PubMed ID: 30464523
[TBL] [Abstract][Full Text] [Related]
31. Downregulation of Rab23 inhibits proliferation, invasion, and metastasis of human ovarian cancer.
Gao L; Zheng M; Guo Q; Nie X; Li X; Hao Y; Liu J; Zhu L; Lin B
Int J Biochem Cell Biol; 2019 Nov; 116():105617. PubMed ID: 31550546
[TBL] [Abstract][Full Text] [Related]
32. Knockdown of RAB25 expression by RNAi inhibits growth of human epithelial ovarian cancer cells in vitro and in vivo.
Fan Y; Xin XY; Chen BL; Ma X
Pathology; 2006 Dec; 38(6):561-7. PubMed ID: 17393986
[TBL] [Abstract][Full Text] [Related]
33. Expression and biological role of δ-catenin in human ovarian cancer.
Fang Y; Li Z; Wang X; Zhang S
J Cancer Res Clin Oncol; 2012 Oct; 138(10):1769-76. PubMed ID: 22699932
[TBL] [Abstract][Full Text] [Related]
34. [Relationship between raf kinase inhibitor protein and metastasis of ovarian carcinoma].
Wang Y; Yang J; Gao Y; Zhao XL; Li HZ; Yao Z
Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):522-8. PubMed ID: 19957553
[TBL] [Abstract][Full Text] [Related]
35. Silencing of IQGAP1 by shRNA inhibits the invasion of ovarian carcinoma HO-8910PM cells in vitro.
Dong PX; Jia N; Xu ZJ; Liu YT; Li DJ; Feng YJ
J Exp Clin Cancer Res; 2008 Nov; 27(1):77. PubMed ID: 19036171
[TBL] [Abstract][Full Text] [Related]
36. Knockdown of UHRF1 by lentivirus-mediated shRNA inhibits ovarian cancer cell growth.
Yan F; Shao LJ; Hu XY
Asian Pac J Cancer Prev; 2015; 16(4):1343-8. PubMed ID: 25743796
[TBL] [Abstract][Full Text] [Related]
37. [Effect of down-regulation of HE4 gene expression on biologic behavior of ovarian cancer cells].
Zhou L; Xiao R; Chen Y; Zhang J; Lu RQ; Guo L
Zhonghua Bing Li Xue Za Zhi; 2013 Oct; 42(10):687-90. PubMed ID: 24433733
[TBL] [Abstract][Full Text] [Related]
38. Epac1 knockdown inhibits the proliferation of ovarian cancer cells by inactivating AKT/Cyclin D1/CDK4 pathway in vitro and in vivo.
Gao M; Ma Y; Bast RC; Li Y; Wan L; Liu Y; Sun Y; Fang Z; Zhang L; Wang X; Wei Z
Med Oncol; 2016 Jul; 33(7):73. PubMed ID: 27277757
[TBL] [Abstract][Full Text] [Related]
39. Silencing the double-stranded RNA binding protein DGCR8 inhibits ovarian cancer cell proliferation, migration, and invasion.
Guo Y; Tian P; Yang C; Liang Z; Li M; Sims M; Lu L; Zhang Z; Li H; Pfeffer LM; Yue J
Pharm Res; 2015 Mar; 32(3):769-78. PubMed ID: 25823356
[TBL] [Abstract][Full Text] [Related]
40. The lncRNA TP73-AS1 promotes ovarian cancer cell proliferation and metastasis via modulation of MMP2 and MMP9.
Wang X; Yang B; She Y; Ye Y
J Cell Biochem; 2018 Sep; 119(9):7790-7799. PubMed ID: 29904939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
